Skip to main content

Table 1 Comparison between the two studied groups according to clinical manifestations

From: Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients

Clinical manifestations

Group A (n = 40)

Group B (n = 40)

χ 2

P

No.

%

No.

%

Anorexia

21

52.5

38

95.0

18.660*

< 0.001*

Fatigue

24

60.0

36

90.0

9.600*

0.002*

Abdominal pain

20

50.0

20

50.0

0.000

1.000

Fever

6

15.0

8

20.0

0.346

0.556

Change in the color of urine and eyes

2

5.0

2

5.0

0.000

FEp = 1.000

Dyspepsia

25

62.5

38

95.0

12.624*

< 0.001*

Vomiting

6

15.0

2

5.0

2.222

FEp = 0.263

Weight loss

4

10.0

10

25.0

3.117

0.077

Cachexia

4

10.0

17

42.5

10.912*

0.001*

Jaundice

2

5.0

2

5.0

0.000

FEp = 1.000

Splenomegaly

16

40.0

20

50.0

0.808

0.369

Hepatomegaly

9

22.5

8

20.0

0.075

0.785

  1. FE Fisher Exact
  2. χ2 Chi square test
  3. p p value for comparing between the studied groups
  4. *Statistically significant at p ≤ 0.05